Search Results

Showing results 11-21 of 103 for 'Cancer'


  • tookad1-tn
    Weizmann Institute Drug, TOOKAD® Soluble, Approved in Mexico for Prostate Cancer Therapy

    Developed by Profs. Yoram Salomon and Avigdor Scherz, the drug TOOKAD<sup>®</sup> Soluble has been approved in Mexico for use in treating prostate cancer. The therapy, which has no side effects, offers men with prostate problems a crucial new option besides surgery or watchful waiting. Late-stage clinical trials have taken place in Europe and continue in the U.S.

    /news-media/news-releases/weizmann-institute-drug-tookad-soluble-approved-in-mexico-for-prostate-cancer-therapy
  • avigdor-scherz-bbc-news-tn
  • 2016-06-acwis-enews-june-thumbnail
    Keeping Men Healthy, the Weizmann Way

    June is Men's Health Month, which aims to raise awareness of preventable problems and promote early detection and treatment of disease. The Weizmann Institute is doing its part, with a prostate cancer treatment receiving approval and investigations into other gender-related cancers; studies on fertility; and learning how women's tears impact men.

    /news-media/feature-stories/keeping-men-healthy-the-weizmann-way
  • Lighting_the_Way_for_a_New_Cancer_Treatment
  • bates-lymphedema-tn
  • Research on Aging at the Weizmann Institute

    As the population in many countries trends towards maturity, keeping people healthy as they age is a priority. At the Weizmann Institute, research is taking place on a number of conditions that often arise later in life, such as prostate cancer and Alzheimer's disease.

    /news-media/feature-stories/research-on-aging-at-the-weizmann-institute
  • kathy-bates-lymphedema-tn
    Kathy Bates: My Battle with Lymphedema

    Oscar winner Kathy Bates opens up to Larry King about developing lymphedema – which occurs when the lymph nodes are removed or blocked – after a double mastectomy. Now a lymphedema activist raising awareness and funds, she gets hope from research like Dr. Karina Yaniv's, whose breakthroughs include being the first to grow lymphatic cells in the lab.

    /news-media/in-the-news/kathy-bates-my-battle-with-lymphedema
  • avigdor-scherz-tn
    Teaming Up to Defeat Prostate Cancer

    Prostate cancer is the second leading cause of cancer-related deaths among American men. That's why Prof. Avigdor Scherz, collaborating with other leading cancer researchers, is developing a promising new treatment: vascular-targeted photodynamic therapy, or VTP. Now in clinical trials, VTP uses light and a unique drug to destroy prostate tumors.

    /news-media/feature-stories/teaming-up-to-defeat-prostate-cancer
  • zelig-eshhar-tn
    Breakthrough Cancer Cure has Deep Israeli Roots

    U.S. scientists have treated blood cancer patients with genetically modified T-cells, and, in what is called an extraordinary development, saw the disease go into remission. As The Times of Israel reports, this true breakthrough began in the lab of Prof. Zelig Eshhar, who created the basis of the technique and has been curing mice of cancer for years.

    /news-media/in-the-news/breakthrough-cancer-cure-has-deep-israeli-roots
  • Weizmann-Institutes-Mathematical-Model-May-Lead-to-Safer-Chemotherapy-thumb